Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Petra Becker, Mikael Rask, Jalal Safipour & A. Birgitta Gunnarsson. (2023) Selfcare Strategies Shown to Be Useful in Daily Life for Adults Diagnosed with Attention Deficit Hyperactivity Disorder – A Systematic Review. Issues in Mental Health Nursing 0:0, pages 1-9.
Read now
Read now
Sara S. McMillan, Bethany Wilson, Helen Stapleton & Amanda J. Wheeler. (2022) Young people's experiences with mental health medication: A narrative review of the qualitative literature. Journal of Mental Health 31:2, pages 281-295.
Read now
Read now
Sercan Belirgan, Mehmet Akif Ersoy & Hatice Topçu Ersoy. (2018) Prevalence of adult attention deficit hyperactivity disorder and comorbid axis-I disorders among first time applied cases of a general psychiatry outpatient clinic and a private psychotherapy centre. Psychiatry and Clinical Psychopharmacology 28:1, pages 25-35.
Read now
Read now
Timothy Wigal, Ann Childress, Glen Frick, Brian Yan, Sharon Wigal & Manisha Madhoo. (2018) Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environment. Postgraduate Medicine 130:1, pages 111-121.
Read now
Read now
Gregory W Mattingly, Joshua Wilson & Anthony L Rostain. (2017) A clinician’s guide to ADHD treatment options. Postgraduate Medicine 129:7, pages 657-666.
Read now
Read now
Tamás Treuer, Luis Méndez, William Montgomery & Shenghu Wu. (2016) Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review. Neuropsychiatric Disease and Treatment 12, pages 1061-1083.
Read now
Read now
Daniel J Walker, Oren Mason, David B Clemow & Kathleen A Day. (2015) Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder. Postgraduate Medicine 127:7, pages 686-701.
Read now
Read now
Articles from other publishers (15)
Rebecca Parkin, Fiona Mc Nicholas & John C. Hayden. (2022) A systematic review of interventions to enhance adherence and persistence with ADHD pharmacotherapy. Journal of Psychiatric Research 152, pages 201-218.
Crossref
Crossref
Raman Baweja, Cesar A Soutullo & James G Waxmonsky. (2021) Review of barriers and interventions to promote treatment engagement for pediatric attention deficit hyperactivity disorder care. World Journal of Psychiatry 11:12, pages 1206-1227.
Crossref
Crossref
Christoph U. Correll, Brittney R. Starling & Michael Huss. (2021) Systematic review of transdermal treatment options in attention-deficit/hyperactivity disorder: implications for use in adult patients. CNS Spectrums, pages 1-13.
Crossref
Crossref
Marianne Haedener, Wolfgang Weinmann, Dominique Eich, Michael Liebrenz, Thomas Wuethrich & Anna Buadze. (2021) Evaluating the reliability of hair analysis in monitoring the compliance of ADHD patients under treatment with Lisdexamphetamine. PLOS ONE 16:3, pages e0248747.
Crossref
Crossref
Carolyn Sikes, Jeffrey G. Stark, Russ McMahen & Dorothy Engelking. (2017) A Single-Dose, Two-Way Crossover, Open-Label Bioequivalence Study of an Amphetamine Extended-Release Oral Suspension in Healthy Adults. Journal of Attention Disorders 24:3, pages 414-419.
Crossref
Crossref
Aisling R. Caffrey & Eric P. Borrelli. (2021) The art and science of drug titration. Therapeutic Advances in Drug Safety 11, pages 204209862095891.
Crossref
Crossref
Michelle Flood, John C. Hayden, Blánaid Gavin & Fiona McNicholas. (2019) A qualitative study exploring the decision of parents to use medication in attention-deficit hyperactivity disorder. Research in Social and Administrative Pharmacy 15:9, pages 1095-1101.
Crossref
Crossref
Barbara D. Fontana, Francini Franscescon, Denis B. Rosemberg, William H.J. Norton, Allan V. Kalueff & Matthew O. Parker. (2019) Zebrafish models for attention deficit hyperactivity disorder (ADHD). Neuroscience & Biobehavioral Reviews 100, pages 9-18.
Crossref
Crossref
Christian Mette. 2020. Handbuch Klinische Psychologie. Handbuch Klinische Psychologie
1
23
.
Odette N. Gould & Clara Doucette. (2016) Self-Management of Adherence to Prescribed Stimulants in College Students With ADD/ADHD. Journal of Attention Disorders 22:4, pages 349-355.
Crossref
Crossref
Tamsin Newlove-Delgado, Tamsin J. Ford, William Hamilton, Ken Stein & Obioha C. Ukoumunne. (2017) Prescribing of medication for attention deficit hyperactivity disorder among young people in the Clinical Practice Research Datalink 2005–2013: analysis of time to cessation. European Child & Adolescent Psychiatry 27:1, pages 29-35.
Crossref
Crossref
Andrew J. Cutler & Gregory W. Mattingly. (2017) Beyond the pill: new medication delivery options for ADHD. CNS Spectrums 22:6, pages 463-474.
Crossref
Crossref
Richelle C. Kosse, Marcel L. Bouvy, Daphne Philbert, Tjalling W. de Vries & Ellen S. Koster. (2017) Attention-Deficit/Hyperactivity Disorder Medication Use in Adolescents: The Patient's Perspective. Journal of Adolescent Health 61:5, pages 619-625.
Crossref
Crossref
Amos Fleishmann & Avigayl Kaliski. (2017) Personal Autonomy and Authenticity: Adolescents’ Discretionary Use of Methylphenidate. Neuroethics 10:3, pages 419-430.
Crossref
Crossref
Asha Hareendran, Juliana Setyawan, Robin Pokrzywinski, Anna Steenrod, Manisha Madhoo & M. Haim Erder. (2015) Evaluating functional outcomes in adolescents with attention-deficit/hyperactivity disorder: development and initial testing of a self-report instrument. Health and Quality of Life Outcomes 13:1.
Crossref
Crossref